» Articles » PMID: 37229927

Multifunctional Nanoparticles for the Treatment and Diagnosis of Osteosarcoma

Overview
Journal Biomater Adv
Date 2023 May 25
PMID 37229927
Authors
Affiliations
Soon will be listed here.
Abstract

Osteosarcoma (OS) is a common primary malignant bone tumor in adolescents. Currently, the commonly used treatment strategies for OS include surgery, chemotherapy and radiotherapy. However, these methods have some problems that cannot be ignored, such as postoperative sequelae and severe side effects. Therefore, in recent years, researchers have been looking for other means to improve the treatment or diagnosis effect of OS and increase the overall survival rate of patients. With the development of nanotechnology, nanoparticles (NPs) have presented excellent properties in improving the therapeutic efficacy of drugs for OS. Nanotechnology makes it possible for NPs to combine various functional molecules and drugs to achieve multiple therapeutic effects. This review presents the important properties of multifunctional NPs for the treatment and diagnosis of OS and focuses on the research progress of common NPs applied for drug or gene delivery, phototherapy and diagnosis of OS, such as carbon-based quantum dots, metal, chitosan and liposome NPs. Finally, the promising prospects and challenges of developing multifunctional NPs with enhanced efficacy are discussed, which lays the foundation and direction for improving the future therapeutic and diagnostic methods of OS.

Citing Articles

The Role of Epithelial-Mesenchymal Transition in Osteosarcoma Progression: From Biology to Therapy.

Patrascu A, Tarca E, Lozneanu L, Ungureanu C, Morosan E, Parteni D Diagnostics (Basel). 2025; 15(5).

PMID: 40075892 PMC: 11898898. DOI: 10.3390/diagnostics15050644.


Gelatin-based biomaterials as a delivery strategy for osteosarcoma treatment.

Yang Q, Chen X, Liu J, He Y Front Pharmacol. 2025; 16:1537695.

PMID: 39936088 PMC: 11811086. DOI: 10.3389/fphar.2025.1537695.


iRGD-Targeted Biosynthetic Nanobubbles for Ultrasound Molecular Imaging of Osteosarcoma.

Liu T, Liang X, Liu W, Yang S, Cui T, Yan F Int J Nanomedicine. 2025; 20:791-805.

PMID: 39867315 PMC: 11760272. DOI: 10.2147/IJN.S494151.


Successful treatment of osteosarcoma in a pregnant woman with survival of the gestational product: A case report and literature review.

Orpinel-Gonzalez C, Iglesias-Gonzalez M, Herrera-Loya J, Martinez-Mendez C, Ramirez-Torres A, Ramirez-Medina R Med Int (Lond). 2024; 4(6):73.

PMID: 39483928 PMC: 11526288. DOI: 10.3892/mi.2024.197.


Abalone shell-derived Mg-doped mesoporous hydroxyapatite microsphere drug delivery system loaded with icariin for inducing apoptosis of osteosarcoma cells.

Liu K, Cheng M, Huang H, Yu H, Zhao S, Zhou J Biomater Transl. 2024; 5(2):185-196.

PMID: 39351158 PMC: 11438601. DOI: 10.12336/biomatertransl.2024.02.008.